Tobias, Deirdre K.
Merino, Jordi
Ahmad, Abrar
Aiken, Catherine
Benham, Jamie L.
Bodhini, Dhanasekaran http://orcid.org/0000-0001-7194-0639
Clark, Amy L.
Colclough, Kevin
Corcoy, Rosa
Cromer, Sara J.
Duan, Daisy http://orcid.org/0000-0002-4392-3206
Felton, Jamie L.
Francis, Ellen C.
Gillard, Pieter
Gingras, Véronique
Gaillard, Romy
Haider, Eram
Hughes, Alice http://orcid.org/0000-0003-1352-4447
Ikle, Jennifer M.
Jacobsen, Laura M.
Kahkoska, Anna R.
Kettunen, Jarno L. T. http://orcid.org/0000-0002-9995-698X
Kreienkamp, Raymond J.
Lim, Lee-Ling
Männistö, Jonna M. E.
Massey, Robert
Mclennan, Niamh-Maire
Miller, Rachel G. http://orcid.org/0000-0003-1845-8477
Morieri, Mario Luca
Most, Jasper
Naylor, Rochelle N.
Ozkan, Bige
Patel, Kashyap Amratlal http://orcid.org/0000-0002-9240-8104
Pilla, Scott J.
Prystupa, Katsiaryna
Raghavan, Sridharan
Rooney, Mary R.
Schön, Martin
Semnani-Azad, Zhila
Sevilla-Gonzalez, Magdalena
Svalastoga, Pernille
Takele, Wubet Worku
Tam, Claudia Ha-ting http://orcid.org/0000-0002-9169-0013
Thuesen, Anne Cathrine B.
Tosur, Mustafa
Wallace, Amelia S.
Wang, Caroline C.
Wong, Jessie J.
Yamamoto, Jennifer M.
Young, Katherine
Amouyal, Chloé
Andersen, Mette K.
Bonham, Maxine P.
Chen, Mingling
Cheng, Feifei
Chikowore, Tinashe
Chivers, Sian C.
Clemmensen, Christoffer http://orcid.org/0000-0003-2456-9667
Dabelea, Dana
Dawed, Adem Y. http://orcid.org/0000-0003-0224-2428
Deutsch, Aaron J. http://orcid.org/0000-0001-6750-5335
Dickens, Laura T.
DiMeglio, Linda A. http://orcid.org/0000-0002-8033-6078
Dudenhöffer-Pfeifer, Monika
Evans-Molina, Carmella http://orcid.org/0000-0001-7764-8663
Fernández-Balsells, María Mercè
Fitipaldi, Hugo
Fitzpatrick, Stephanie L.
Gitelman, Stephen E.
Goodarzi, Mark O. http://orcid.org/0000-0001-6364-5103
Grieger, Jessica A.
Guasch-Ferré, Marta
Habibi, Nahal
Hansen, Torben http://orcid.org/0000-0001-8748-3831
Huang, Chuiguo
Harris-Kawano, Arianna
Ismail, Heba M.
Hoag, Benjamin
Johnson, Randi K.
Jones, Angus G. http://orcid.org/0000-0002-0883-7599
Koivula, Robert W.
Leong, Aaron
Leung, Gloria K. W.
Libman, Ingrid M.
Liu, Kai
Long, S. Alice http://orcid.org/0000-0002-0281-1240
Lowe, William L. Jr http://orcid.org/0000-0001-9467-3422
Morton, Robert W.
Motala, Ayesha A.
Onengut-Gumuscu, Suna http://orcid.org/0000-0002-6563-8334
Pankow, James S. http://orcid.org/0000-0001-7076-483X
Pathirana, Maleesa
Pazmino, Sofia
Perez, Dianna
Petrie, John R.
Powe, Camille E.
Quinteros, Alejandra
Jain, Rashmi
Ray, Debashree http://orcid.org/0000-0002-0979-2935
Ried-Larsen, Mathias http://orcid.org/0000-0002-8388-5291
Saeed, Zeb
Santhakumar, Vanessa
Kanbour, Sarah
Sarkar, Sudipa
Monaco, Gabriela S. F.
Scholtens, Denise M. http://orcid.org/0000-0002-8252-7863
Selvin, Elizabeth http://orcid.org/0000-0002-3539-2070
Sheu, Wayne Huey-Herng
Speake, Cate http://orcid.org/0000-0003-1480-4272
Stanislawski, Maggie A.
Steenackers, Nele
Steck, Andrea K.
Stefan, Norbert http://orcid.org/0000-0002-2186-9595
Støy, Julie
Taylor, Rachael
Tye, Sok Cin
Ukke, Gebresilasea Gendisha
Urazbayeva, Marzhan
Van der Schueren, Bart
Vatier, Camille
Wentworth, John M.
Hannah, Wesley
White, Sara L.
Yu, Gechang
Zhang, Yingchai
Zhou, Shao J.
Beltrand, Jacques
Polak, Michel
Aukrust, Ingvild
de Franco, Elisa
Flanagan, Sarah E.
Maloney, Kristin A. http://orcid.org/0000-0002-8607-1146
McGovern, Andrew
Molnes, Janne
Nakabuye, Mariam
Njølstad, Pål Rasmus http://orcid.org/0000-0003-0304-6728
Pomares-Millan, Hugo
Provenzano, Michele
Saint-Martin, Cécile
Zhang, Cuilin
Zhu, Yeyi
Auh, Sungyoung
de Souza, Russell
Fawcett, Andrea J.
Gruber, Chandra
Mekonnen, Eskedar Getie
Mixter, Emily
Sherifali, Diana
Eckel, Robert H.
Nolan, John J.
Philipson, Louis H.
Brown, Rebecca J.
Billings, Liana K.
Boyle, Kristen http://orcid.org/0000-0001-9689-3322
Costacou, Tina
Dennis, John M. http://orcid.org/0000-0002-7171-732X
Florez, Jose C. http://orcid.org/0000-0002-1730-9325
Gloyn, Anna L. http://orcid.org/0000-0003-1205-1844
Gomez, Maria F. http://orcid.org/0000-0001-6210-3142
Gottlieb, Peter A.
Greeley, Siri Atma W.
Griffin, Kurt
Hattersley, Andrew T. http://orcid.org/0000-0001-5620-473X
Hirsch, Irl B.
Hivert, Marie-France http://orcid.org/0000-0001-7752-2585
Hood, Korey K.
Josefson, Jami L.
Kwak, Soo Heon http://orcid.org/0000-0003-1230-0919
Laffel, Lori M.
Lim, Siew S.
Loos, Ruth J. F.
Ma, Ronald C. W. http://orcid.org/0000-0002-1227-803X
Mathieu, Chantal
Mathioudakis, Nestoras
Meigs, James B.
Misra, Shivani http://orcid.org/0000-0003-2886-0726
Mohan, Viswanathan http://orcid.org/0000-0001-5038-6210
Murphy, Rinki http://orcid.org/0000-0002-0043-2423
Oram, Richard http://orcid.org/0000-0003-3581-8980
Owen, Katharine R. http://orcid.org/0000-0003-3982-1407
Ozanne, Susan E. http://orcid.org/0000-0001-8753-5144
Pearson, Ewan R. http://orcid.org/0000-0001-9237-8585
Perng, Wei
Pollin, Toni I.
Pop-Busui, Rodica
Pratley, Richard E.
Redman, Leanne M.
Redondo, Maria J.
Reynolds, Rebecca M.
Semple, Robert K. http://orcid.org/0000-0001-6539-3069
Sherr, Jennifer L. http://orcid.org/0000-0001-9301-3043
Sims, Emily K. http://orcid.org/0000-0002-4393-954X
Sweeting, Arianne
Tuomi, Tiinamaija http://orcid.org/0000-0002-8306-6202
Udler, Miriam S. http://orcid.org/0000-0003-3824-9162
Vesco, Kimberly K.
Vilsbøll, Tina
Wagner, Robert http://orcid.org/0000-0002-6120-0191
Rich, Stephen S. http://orcid.org/0000-0003-3872-7793
Franks, Paul W. http://orcid.org/0000-0002-0520-7604
Funding for this research was provided by:
European Commission (ERC-CoG_NASCENT-681742)
Vetenskapsrådet (2014-03529)
Article History
Received: 17 May 2023
Accepted: 14 July 2023
First Online: 5 October 2023
Competing interests
: The following authors report unrelated disclosures. J. Merino. is an Associate Editor of Diabetologia; S.J.C. reports a close family member employed by a Johnson & Johnson company; A.R.K. is supported by the National Center for Advancing Translational Sciences, NIH, through grant KL2TR002490. A.R.K. also reports receiving research grants from the Diabetes Research Connection and the American Diabetes Association, and a research prize from the National Academy of Medicine, outside the submitted work; J.L.T.K. declares lecture fees from Novo Nordisk, international conference costs covered by Medtronic, AstraZeneca and Novo Nordisk; L.-L.L. reports receiving research grants via her academic institution and serving on an advisory board for Boehringer Ingelheim, Novartis, Novo Nordisk, Viatris Pharmaceutical and Zuellig Pharma. L.-L.L. has received speaking honoraria from Abbott, Amgen, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Roche, Sanofi, Servier, Viatris Pharmaceutical and Zuellig Pharma for scientific talks over which she had full control of the content; R.M. has received consulting or speaker honoraria from Eli Lilly, Novo Nordisk and Boeringer Engelheim; M.L.M. has received lecture, consultancy, or advisory board fees from Amarin, Amgen, Eli Lilly, Merck Sharp & Dohme, Mylan, Novo Nordisk, Novartis, Servier and SlaPharma; C.E.-M. reports serving on advisory boards for Provention Bio, Isla Technologies, MaiCell Technologies, Avotres, DiogenyX and Neurodon; receiving in-kind research support from Bristol Myers Squibb and Nimbus Pharmaceuticals; receiving investigator-initiated grants from Lilly Pharmaceuticals and Astellas Pharmaceuticals; and having patent (16/291,668) Extracellular Vesicle Ribonucleic Acid (RNA) Cargo as a Biomarker of Hyperglycaemia and Type 1 Diabetes and provisional patent (63/285,765) Biomarker for Type 1 Diabetes (PDIA1 as a biomarker of β cell stress); S.E.G. has been on advisory boards for Abata, Avotres, Genentech, GentiBio, Provention Bio, Sana Biotechnology, Sanofi and is a DSMB member for INNODIA (MELD, ATG), Diamyd (DIAGNODE-3, GAD) and JDRF (TADPOL, DFMO); M.O.G. has served on an advisory board for Nestle Health Science; A.L. reports a close family member employed by Merck & Co., Inc.; C.E.P. is an Associate Editor of Diabetes Care, receives payments from Wolters Kluwer for UpToDate chapters on diabetes in pregnancy and has received payments for consulting and speaking from Mediflix Inc; E.S. is a Deputy Editor of Diabetes Care and a member of the editorial board of Diabetologia and receives payments from Wolters Kluwer for chapters and laboratory monographs in UpToDate on measurements of glycemic control and screening tests for type 2 diabetes; W.H.H.S. has been an Advisor and/or Speaker for AstraZeneca, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, Eli Lilly and Company, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals, Novo Nordisk, Pfizer, Sanofi-Aventis, Takeda Pharmaceutical Company; J.M.W. reports a research collaboration with ENABLE Biosciences; R.J.B. has received research support from Amryt, Third Rock Ventures, Ionis and Regeneron; L.K.B. has received consulting honoraria from Bayer, Novo Nordisk, Sanofi, Lilly and Xeris; J.C.F. has received speaking honoraria from AstraZeneca and Novo Nordisk for scientific talks over which he had full control of content; A.L.G.’s spouse holds stock options in Roche and is an employee of Genentech; M.F.G. has received financial and nonfinancial (in kind) support from Boehringer Ingelheim Pharma GmbH, JDRF International, Eli Lilly, AbbVie, Sanofi-Aventis, Astellas, Novo Nordisk A/S, Bayer AG, within EU grant H2020-JTI-lMl2-2015-05 (grant agreement number 115974 - BEAt-DKD); and also from Novo Nordisk, Pfizer, Follicum, Coegin Pharma, Abcentra, Probi, Johnson & Johnson, within a project funded by the Swedish Foundation for Strategic Research on precision medicine in diabetes (LUDC-IRC no. 15-0067). M.F.G. has received personal consultancy fees from Lilly and Tribune Therapeutics AB. R.dS. has served as an external resource person to the World Health Organization’s Nutrition Guidelines Advisory Group on trans fats, saturated fats, and polyunsaturated fats. The WHO paid for his travel and accommodation to attend meetings from 2012 to 2017 to present and discuss this work. He has presented updates of this work to the WHO in 2022. He has also done contract research for the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism, and Diabetes, Health Canada, and the World Health Organization for which he received remuneration. He has received speaker’s fees from the University of Toronto, and McMaster Children’s Hospital. He has served as an independent director of the Helderleigh Foundation (Canada). He serves as a member of the Nutrition Science Advisory Committee to Health Canada (Government of Canada), co-chair of the Method working group of the ADA/EASD Precision Medicine in Diabetes group and is a co-opted member of the Scientific Advisory Committee on Nutrition (SACN) Subgroup on the Framework for the Evaluation of Evidence (Public Health England). He has held grants from the Canadian Institutes of Health Research, Canadian Foundation for Dietetic Research, Population Health Research Institute, and Hamilton Health Sciences Corporation as a principal investigator, and is a co-investigator on several funded team grants from the Canadian Institutes of Health Research. P.A.G. consults or has consulted for Provention Bio and Viacyte. He is the cofounder of IM Therapeutics and serves as CMO on the Board as well as being a shareholder. P.A.G. has also received research support from Helmsley Foundation, Nova Pharmaceuticals, Imcyse, Provention Bio, Intrexon T1D Partners and Novartis. All payments have been made to the University of Colorado; R.C.W.M. has received research grants from AstraZeneca, Bayer, Novo Nordisk, Pfizer, Roche Diagnostics (HK) Ltd, Tricida Inc, and consultancy/speaker honorarium from AstraZeneca, Boehringer Ingelheim, Bayer and Merck. All proceeds have been donated to the Chinese University of Hong Kong to support diabetes research. R.C.W.M. is a cofounder of GemVCare, a technology start-up initiated with support from the Hong Kong Government Innovation and Technology Commission and its Technology Start-up Support Scheme for Universities (TSSSU); C.M. serves or has served on the advisory panel for Novo Nordisk, Sanofi, Merck Sharp and Dohme Ltd., Eli Lilly and Company, Novartis, AstraZeneca, Boehringer Ingelheim, Roche, Medtronic, ActoBio Therapeutics, Pfizer, Imcyse, Insulet, Zealand Pharma, Avotres, Mannkind, Sandoz and Vertex. Financial compensation for these activities has been received by KU Leuven; KU Leuven has received research support for C.M. from Medtronic, Imcyse, Novo Nordisk, Sanofi and ActoBio Therapeutics; C.M. serves or has served on the speakers’ bureau for Novo Nordisk, Sanofi, Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca and Novartis. Financial compensation for these activities has been received by KU Leuven. C.M. has been an Advisor and/or Speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi-Aventis. C.M. is president of EASD (all external support of EASD is to be found on ExternalRef removed); N.S. is Senior Associate Editor of Diabetes and has received speaking honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer and Sanofi for scientific talks over which he had full control of content; J.B.M. is an Academic Associate for Quest Inc. Diagnostics R&D; S.M. has investigator-initiated funding from DexCom, has received speaker fees from Sanofi for a scientific talk over which she had full control of content and serves on the Board of Trustees for the Diabetes Research & Wellness Foundation (UK); V.M. has acted as consultant and speaker, received research or educational grants from Novo Nordisk, MSD, Eli Lilly, Novartis, Boehringer Ingelheim, Lifescan J&J, Sanofi-Aventis, Roche Diagnostics, Abbott and from several Indian pharmaceutical companies including USV, Dr. Reddy’s Laboratories and Sun Pharma. E.R.P. has received speaking honoraria from Lilly, Novo Nordisk and Illumina for scientific talks over which he had full control of content; J.L.S. serves or has served on advisory panels for Bigfoot Biomedical, Cecelia Health, Insulet Corportation, Medtronic Diabetes, StartUp Health Diabetes Moonshot and Vertex. She has served as a consultant to Abott Diabetes, Bigfoot Biomedical, Insulet, Medtronic Diabetes and Zealand. Yale School of Medicine has received research support for JLS from Abott Diabetes, JAEB Center for Health Research, JDRF, Insulet, Medtronic, NIH and Provention Bio; M.S.U. reports an unpaid collaborator with AstraZeneca; K.K.V. reports that her institution received funding from Pfizer Independent Grants for Learning and Change for an unrelated study. R.W. declares lecture fees from Novo Nordisk, Sanofi and Eli Lilly. He served on an advisory board for Akcea Therapeutics, Daiichi Sankyo, Sanofi, Eli Lilly and Novo Nordisk; P.W.F. has received consulting fees from Zoe Ltd and research grants from multiple pharmaceutical companies; R.W.M. and P.W.F. are employees of the Novo Nordisk Foundation, a private philanthropic enterprise foundation based in Denmark supporting research and education in the life sciences. All other authors report no disclosures.
Free to read: This content has been made available to all.